The test identifies genetic predispositions in four critical areas: GLP-1 receptor sensitivity, glucose-dependent insulinotropic receptor (GIPR) function, melanocortin-4 receptor (MC4R) signaling, and fat mass and obesity-associated (FTO) gene variants
With a focus on innovation, safety, and patient-centered care, we strive to provide you with treatments that support your overall wellness and improve your quality of life
GLP-1 agonists work through distinct mechanismsenhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and promoting central satiety signaling
Sleep disturbances are a significant concern that affect approximately 35%60% of menopausal women, so achieving restful sleep is essential
Slowed Gut Motility Throughout Digestive Tract Ozempics primary mechanism is activating GLP-1 receptors throughout your digestive system